A University of Southampton study has found that combining two different immunotherapy treatments could dramatically improve lymphoma survival.
Dr Sean Lim, who led the study, said: “By combining two specific antibodies we’ve increased the ability of the immune system to destroy cancer cells. It’s very exciting to see that this drug combination has an impact on survival.”
Copy and paste this URL into your WordPress site to embed
